ALB and colorectal cancer: For example, the ratio of fibrinogen to pre-albumin (FPR) as well as its combination with SII were found to be superior to other inflammatory biomarkers for predicting the overall survival among patients with advanced NSCLC (27) or early recurrence among stage II-III colorectal cancer patients after curable resection (28).